SE9400918L - Stabiliserad komposition för oral administrering av peptider - Google Patents

Stabiliserad komposition för oral administrering av peptider

Info

Publication number
SE9400918L
SE9400918L SE9400918A SE9400918A SE9400918L SE 9400918 L SE9400918 L SE 9400918L SE 9400918 A SE9400918 A SE 9400918A SE 9400918 A SE9400918 A SE 9400918A SE 9400918 L SE9400918 L SE 9400918L
Authority
SE
Sweden
Prior art keywords
pct
oral administration
spheres
sec
peptides
Prior art date
Application number
SE9400918A
Other languages
Unknown language ( )
English (en)
Other versions
SE9400918D0 (sv
Inventor
Anne Fjellstad-Paulsen
Christina Ahlm-Soederberg
Original Assignee
Anne Fjellstad Paulsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anne Fjellstad Paulsen filed Critical Anne Fjellstad Paulsen
Priority to SE9400918A priority Critical patent/SE9400918L/sv
Publication of SE9400918D0 publication Critical patent/SE9400918D0/sv
Priority to JP52457095A priority patent/JP3249970B2/ja
Priority to PL95316412A priority patent/PL181866B1/pl
Priority to SK1185-96A priority patent/SK281640B6/sk
Priority to KR1019960705056A priority patent/KR100289141B1/ko
Priority to CZ962676A priority patent/CZ285810B6/cs
Priority to DK95914605T priority patent/DK0752877T3/da
Priority to PT95914605T priority patent/PT752877E/pt
Priority to PCT/SE1995/000249 priority patent/WO1995025534A1/en
Priority to ES95914605T priority patent/ES2149979T3/es
Priority to AU21517/95A priority patent/AU679852B2/en
Priority to US08/676,400 priority patent/US5763405A/en
Priority to RO96-01820A priority patent/RO115123B1/ro
Priority to CA002183862A priority patent/CA2183862C/en
Priority to EP95914605A priority patent/EP0752877B1/en
Priority to BR9506989A priority patent/BR9506989A/pt
Priority to HU9602544A priority patent/HU214826B/hu
Priority to CN95192114A priority patent/CN1143911A/zh
Priority to NZ283462A priority patent/NZ283462A/en
Priority to RU96121338A priority patent/RU2140790C1/ru
Priority to DE69517801T priority patent/DE69517801T2/de
Priority to AT95914605T priority patent/ATE194290T1/de
Publication of SE9400918L publication Critical patent/SE9400918L/sv
Priority to NO19963884A priority patent/NO316055B1/no
Priority to FI963679A priority patent/FI114688B/sv
Priority to GR20000402132T priority patent/GR3034440T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
SE9400918A 1994-03-18 1994-03-18 Stabiliserad komposition för oral administrering av peptider SE9400918L (sv)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE9400918A SE9400918L (sv) 1994-03-18 1994-03-18 Stabiliserad komposition för oral administrering av peptider
AT95914605T ATE194290T1 (de) 1994-03-18 1995-03-09 Stabilisierte zusammensetzung zur oralen verabreichung von peptiden
RO96-01820A RO115123B1 (ro) 1994-03-18 1995-03-09 Compozitie farmaceutica solida pentru administrare orala
EP95914605A EP0752877B1 (en) 1994-03-18 1995-03-09 Stabilized composition for oral administration of peptides
SK1185-96A SK281640B6 (sk) 1994-03-18 1995-03-09 Pevná farmaceutická kompozícia na orálne podávanie polypeptidu
KR1019960705056A KR100289141B1 (ko) 1994-03-18 1995-03-09 펩타이드의 경구 투여를 위한 안정화된 조성물
CZ962676A CZ285810B6 (cs) 1994-03-18 1995-03-09 Stabilní kompozice pro orální podávání peptidů a způsob výroby jednotkové dávky této kompozice
DK95914605T DK0752877T3 (da) 1994-03-18 1995-03-09 Stabiliseret sammensætning til oral indgift af peptider
PT95914605T PT752877E (pt) 1994-03-18 1995-03-09 Composicao estabilizada para a administracao de peptidos por via oral
PCT/SE1995/000249 WO1995025534A1 (en) 1994-03-18 1995-03-09 Stabilized composition for oral administration of peptides
ES95914605T ES2149979T3 (es) 1994-03-18 1995-03-09 Composicion estabilizada para la administracion oral de peptidos.
AU21517/95A AU679852B2 (en) 1994-03-18 1995-03-09 Stabilized composition for oral administration of peptides
US08/676,400 US5763405A (en) 1994-03-18 1995-03-09 Stabilized composition for oral administration of peptides
JP52457095A JP3249970B2 (ja) 1994-03-18 1995-03-09 ペプチドを経口投与するための安定化組成物
CA002183862A CA2183862C (en) 1994-03-18 1995-03-09 Stabilized composition for oral administration of peptides
PL95316412A PL181866B1 (pl) 1994-03-18 1995-03-09 Preparat do doustnego podawania peptydów w postaci tabletki lub kapsulki i sposób wytwarzania preparatu do doustnego podawania peptydów w postaci tabletki lub kapsulki PL PL PL PL PL PL
BR9506989A BR9506989A (pt) 1994-03-18 1995-03-09 Composição farmacêutica processo de fabricação de doses unitárias de composição e processo para a administração a um paciente de uma dose unitária de vasopressina oxitocina e seus análogos
HU9602544A HU214826B (hu) 1994-03-18 1995-03-09 Peptidek orális adagolására szolgáló stabilizált gyógyászati készítmény és előállítása
CN95192114A CN1143911A (zh) 1994-03-18 1995-03-09 用于口服的肽类的稳定化组合物
NZ283462A NZ283462A (en) 1994-03-18 1995-03-09 Medicament in solid form for oral adminstration of vasopressin, oxytocin or analogues thereof
RU96121338A RU2140790C1 (ru) 1994-03-18 1995-03-09 Стабилизированная композиция для перорального введения пептидов
DE69517801T DE69517801T2 (de) 1994-03-18 1995-03-09 Stabilisierte zusammensetzung zur oralen verabreichung von peptiden
FI963679A FI114688B (sv) 1994-03-18 1996-09-17 Stabiliserad sammansättning för oral administration av peptider
NO19963884A NO316055B1 (no) 1994-03-18 1996-09-17 Stabilisert sammensetning for oral administrasjon av peptider
GR20000402132T GR3034440T3 (en) 1994-03-18 2000-09-20 Stabilized composition for oral administration of peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9400918A SE9400918L (sv) 1994-03-18 1994-03-18 Stabiliserad komposition för oral administrering av peptider

Publications (2)

Publication Number Publication Date
SE9400918D0 SE9400918D0 (sv) 1994-03-18
SE9400918L true SE9400918L (sv) 1995-09-19

Family

ID=20393330

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9400918A SE9400918L (sv) 1994-03-18 1994-03-18 Stabiliserad komposition för oral administrering av peptider

Country Status (24)

Country Link
US (1) US5763405A (sv)
EP (1) EP0752877B1 (sv)
JP (1) JP3249970B2 (sv)
CN (1) CN1143911A (sv)
AT (1) ATE194290T1 (sv)
AU (1) AU679852B2 (sv)
BR (1) BR9506989A (sv)
CA (1) CA2183862C (sv)
CZ (1) CZ285810B6 (sv)
DE (1) DE69517801T2 (sv)
DK (1) DK0752877T3 (sv)
ES (1) ES2149979T3 (sv)
FI (1) FI114688B (sv)
GR (1) GR3034440T3 (sv)
HU (1) HU214826B (sv)
NO (1) NO316055B1 (sv)
NZ (1) NZ283462A (sv)
PL (1) PL181866B1 (sv)
PT (1) PT752877E (sv)
RO (1) RO115123B1 (sv)
RU (1) RU2140790C1 (sv)
SE (1) SE9400918L (sv)
SK (1) SK281640B6 (sv)
WO (1) WO1995025534A1 (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
DK1473029T3 (da) * 2003-04-30 2005-04-18 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ATE301990T1 (de) 2003-07-25 2005-09-15 Ferring Bv Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
ATE324869T1 (de) * 2003-11-13 2006-06-15 Ferring Bv Blisterverpackung und feste dosierungsform enthaltend desmopressin
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
KR101522747B1 (ko) 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
HUE039013T4 (hu) * 2008-05-21 2019-08-28 Ferring Bv Orodiszperzibilis dezmopresszin az alvás noktúria által meg nem zavart kezdeti szakaszának megnövelésére
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
KR101792696B1 (ko) 2009-06-18 2017-11-02 알레간 인코포레이티드 안전한 데스모프레신 투여
DK2598553T3 (da) * 2010-07-26 2016-08-01 Univ Geneve Sammensætninger omfattende polymerer fremstillede af 2-hydroxyalkylsyrer
CN102146122A (zh) * 2010-11-12 2011-08-10 深圳市健元医药科技有限公司 一种具有宫缩作用药物的生产工艺
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
JP6607508B2 (ja) * 2014-10-01 2019-11-20 オキシトーン バイオサイエンス ビー．ブイ． 分娩制御物質を含有する口腔内崩壊性固形医薬投与単位
WO2019180561A1 (en) 2018-03-20 2019-09-26 Mankind Pharma Ltd. Stable pharmaceutical composition of vasopressin
JP2022501440A (ja) 2018-09-20 2022-01-06 リーヴォ セラピューティクス， インコーポレイテッド カルベトシン医薬品およびその製造プロセス
JP2021529220A (ja) 2018-09-20 2021-10-28 リーヴォ セラピューティクス， インコーポレイテッド カルベトシンの安定的鼻腔内製剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
EP0708657B1 (en) * 1993-06-29 2001-07-25 Ferring B.V. Compositions for nasal administration of desmopressin
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin

Also Published As

Publication number Publication date
CZ267696A3 (en) 1997-05-14
DE69517801T2 (de) 2001-02-22
JP3249970B2 (ja) 2002-01-28
PL181866B1 (pl) 2001-09-28
DK0752877T3 (da) 2000-10-16
FI963679A0 (sv) 1996-09-17
CA2183862A1 (en) 1995-09-28
SK281640B6 (sk) 2001-06-11
SE9400918D0 (sv) 1994-03-18
PL316412A1 (en) 1997-01-06
CZ285810B6 (cs) 1999-11-17
NO316055B1 (no) 2003-12-08
NZ283462A (en) 1997-03-24
RU2140790C1 (ru) 1999-11-10
RO115123B1 (ro) 1999-11-30
FI114688B (sv) 2004-12-15
HUT74878A (en) 1997-02-28
GR3034440T3 (en) 2000-12-29
WO1995025534A1 (en) 1995-09-28
ES2149979T3 (es) 2000-11-16
SK118596A3 (en) 1997-04-09
PT752877E (pt) 2000-12-29
AU2151795A (en) 1995-10-09
HU9602544D0 (en) 1996-11-28
JPH10503467A (ja) 1998-03-31
CN1143911A (zh) 1997-02-26
FI963679A (sv) 1996-09-17
CA2183862C (en) 2001-10-23
EP0752877B1 (en) 2000-07-05
AU679852B2 (en) 1997-07-10
US5763405A (en) 1998-06-09
BR9506989A (pt) 1997-09-16
NO963884L (no) 1996-09-17
HU214826B (hu) 1998-06-29
ATE194290T1 (de) 2000-07-15
EP0752877A1 (en) 1997-01-15
NO963884D0 (no) 1996-09-17
DE69517801D1 (de) 2000-08-10

Similar Documents

Publication Publication Date Title
FI114688B (sv) Stabiliserad sammansättning för oral administration av peptider
SE9300937L (sv) Komposition för oral administrering av peptider
EP0225189A3 (en) Targeted enteral delivery system
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
EP1275381A4 (en) SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION
ES2006649A6 (es) Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma.
SE8306367D0 (sv) Antidiuretiskt verkande farmaceutiskt preparat
KR850700212A (ko) 서방성 약제학적 캼셀제
RU2449796C9 (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
IL41524A (en) Pharmaceutical preparations containing the product of proline
MX9802026A (es) Formulaciones farmaceuticas que contienen darifenacina.
TH61079A (th) ยาเม็ดเคลือบฟิล์มสำหรับความปลอดภัยที่ดีขึ้นสำหรับทางเดินกระเพาะลำไส้ตอนบน
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
TH31107B (th) ยาเม็ดเคลือบฟิล์มสำหรับความปลอดภัยที่ดีขึ้นสำหรับทางเดินกระเพาะลำไส้ตอนบน

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9400918-0